GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Satudora Holdings Co Ltd (TSE:3544) » Definitions » Research & Development

Satudora Holdings Co (TSE:3544) Research & Development : 円0 Mil (TTM As of May. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Satudora Holdings Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Satudora Holdings Co's Research & Development for the three months ended in May. 2024 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in May. 2024 was 円0 Mil.

Satudora Holdings Co Research & Development Historical Data

The historical data trend for Satudora Holdings Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Satudora Holdings Co Research & Development Chart

Satudora Holdings Co Annual Data
Trend Feb15 Feb16 May17 May18 May19 May20 May21 May22 May23 May24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Satudora Holdings Co Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Satudora Holdings Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in May. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Satudora Holdings Co  (TSE:3544) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Satudora Holdings Co Research & Development Related Terms

Thank you for viewing the detailed overview of Satudora Holdings Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Satudora Holdings Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Satudora Holdings Co Ltd (TSE:3544) » Definitions » Research & Development
Comparable Companies
TSE:3417 TSE:4350 TSE:2796 TSE:9776 TSE:2934 TSE:7129 TSE:3341 WBA BSP:RADL3 HKSE:00241 TSE:3088 SAU:4164 SHSE:603939 TSE:3349 SHSE:600998 HKSE:09885 TSE:3391 TSE:3141 JSE:CLS TSE:9989
Traded in Other Exchanges
3544:Japan
Address
1-2-18 Taihei 3-jo, Kita-ku Sapporo, Hokkaido, Sapporo, JPN, 002-8003
Website
http://www.sapporo-drug.co.jp
Satudora Holdings Co Ltd operates as a pharmaceutical retailer. The business of the company includes operating drug store, regional marketing, dispensing, wholesale and product development, and energy business.

Satudora Holdings Co Headlines

No Headlines